Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia [Phase 3]

View source ↗

Summary

Phase 3 trial (APPLE) is evaluating whether aspirin can prevent pregnancy loss and preeclampsia, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Pre-Eclampsia, Pregnancy Loss | Phase 3 | Status: RECRUITING